Search clinical trials for: Patient and Public Involvement (PPI)

Total 476620 results

Presidio Pharmaceuticals, Inc.

Completed

Phase 1 Study of Relative Bioavailability of PPI-668 Tablet and Capsule Formulations

Pharmacokinetic Assessments in Healthy Volunteers

United States
KU Leuven

Completed

Acid Pocket: Position and Aspiration

Healthy Volunteers | Barrett Esophagus | GERD - PPI Responders | GERD - PPI Non-responders

Belgium
HaEmek Medical Center, Israel

Completed

Prepulse Inhibition (PPI) of Startle Reflex in Schizophrenia Patients Related to Type of Treatment and Illness Duration

Schizophrenia | Medication Adherence | Inhibition (Psychology)

Israel
Central Hospital, Nancy, France

Not yet recruiting

Evaluation of the "Pupillary Pain Index" in Neurological Prognosis After Cardiac Arrest (CAPPI)

Cardiac Arrest | Anoxic Brain Injury | Post-Anoxic Coma
Presidio Pharmaceuticals, Inc.

Completed

Phase 1 Study of Relative Bioavailability of PPI-668 New Tablet Versus Capsule Formulations

Pharmacokinetic Assessments in Healthy Volunteers

United States
PRAECIS Pharmaceuticals Inc.

Completed

Safety Study of PPI-1019 in Patients With Mild-Moderate Alzheimer's Disease

Alzheimer's Disease

United States
PRAECIS Pharmaceuticals Inc.

Terminated

Safety/Tolerance Study of PPI-2458 in Subjects With Non-Hodgkin's Lymphoma and Solid Tumors

Solid Tumors | Non-Hodgkin's Lymphoma,

United States
PRAECIS Pharmaceuticals Inc.

Completed

Safety Study of PPI-1019 in Subjects With Mild-Moderate Alzheimer's Disease

Alzheimer's Disease

United States
Shire

Completed

Selective 5-HT4 Receptor Agonist and Proton Pump Inhibitor (PPI) in Subjects With Gastroesophageal Reflux Disease (GERD)

Gastroesophageal Reflux Disease

United States, Czechia, Germany, Latvia, Poland, Romania
Al-Azhar University

Not yet recruiting

Minimally Invasive Scrotal Incision for Penile Prosthesis Implantation, Novel Technique. (PPI)

Penile Prosthesis Infection | Penile Prosthesis; Complications, Infection or Inflammation
Rabin Medical Center

Withdrawn

Gastric Acid Rebound Secretion Measured by Alkaline Tide

Condition Measuring Alkaline Tide and Filling Symptoms' Questionnaire After Abrupt or Gradual Step Down Cessation of PPI
Braintree Laboratories

Recruiting

A Study to Evaluate the Efficacy and Safety of BLI5100 in Patients With Erosive Esophagitis

Erosive Esophagitis

United States
KK Women's and Children's Hospital

Recruiting

Integrated Psychological Program for Management of Postnatal Depression and Persistent Postpartum Pain After Childbirth (CODEPAD-II)

Depression, Postpartum

Singapore
Medical University of Graz

Completed

Probiotic Modulation of Intestinal Microbiota in Long-term Intake of Proton Pump Inhibitors

Patients on Long-term Proton Pump Inhibitor Therapy

Austria
Novartis

Completed

Assessment of the Effects of Tegaserod in the Management of Gastroesophageal Reflux Disease (GERD) in Patients With Incomplete Response to Proton Pump Inhibitors (PPIs).

Gastroesophageal Reflux Disease (GERD)

United States
Zhongshan Ophthalmic Center, Sun Yat-sen University

Completed

Prophylactic Peripheral Iridectomy Prevents Aphakic Angle-closure Glaucoma

Congenital Cataract | Aphakic Glaucoma

China
University of Southern California

Withdrawn

PPI Versus Placebo in Severe Functional Heartburn

GERD

United States
Il-Yang Pharm. Co., Ltd.

Completed

Phase III Study to Evaluate Safety and Efficacy of Ilaprazole in Patients With NERD

Non-erosive Reflux Disease

Korea, Republic of
Centre Hospitalier Universitaire de Nice

Not yet recruiting

Inorganic Pyrophosphate Homeostasis (PPi) in Pediatric Chronic Kidney Disease (PPi-DIA)

Pyrophosphate, Fetuin A, IL1, IL6, TNFalpha, Control

France
Tanta University

Recruiting

Penile Prosthesis in Patients With Erectile Dysfunction

Erectile Dysfunction

Egypt
Presidio Pharmaceuticals, Inc.

Completed

A Phase 1b Study of PPI-461 in Patients With HCV Genotype 1

Chronic Genotype 1 Hepatitis C Virus Infection

United Kingdom, Denmark, United States
AstraZeneca

Completed

Symptoms and Management Strategies in Gastroesophageal Reflux Disease (GERD) (PHENIX)

Gastroesophageal Reflux Disease

Croatia
Presidio Pharmaceuticals, Inc.

Completed

A Phase 1 Study of PPI-668 in Healthy Volunteers and Patients With Hepatitis C Virus (HCV) Genotype 1

Hepatitis C, Chronic

United States, Australia, New Zealand
AstraZeneca

Completed

Drug Interaction Study Between AZD3355 and Nexium

Gastroesophageal Reflux Disease

Sweden
Soonchunhyang University Hospital

Completed

Surgicel® Fibrillar for Delayed Bleeding After ESD

Malignant Neoplasm of Stomach | Benign Neoplasm of Stomach

Korea, Republic of
Yonsei University

Completed

Efficacy of Proton Pump Inhibitor for Chronic Cough Caused by Gastroesophageal Reflux; Double-blind, Placebo-controlled, Randomized Clinical Trial

Chronic Cough Caused by Gastroesophageal Reflux

Korea, Republic of
AstraZeneca
i3 Innovus

Completed

Partial Response to PPI Treatment: The Cost to Society and the Burden to the Patient - a Study in France (REMAIN)

Gastroesophageal Reflux Disease

France
Albert J. Chang

Withdrawn

Hypofractionated Whole Pelvic Radiotherapy of the Prostate

Prostate Cancer
Nantes University Hospital

Completed

Efficacy of a Multi-faceted Intervention to Deprescribe Proton Pump Inhibitors (PPI) in Primary Care: a Population-based, Pragmatic, Cluster-randomized Controlled Trial. (DeprescrIPP)

Proton Pump Inhibitors | Deprescription

France
Centre Hospitalier Universitaire Dijon

Completed

the Impact of Paediatric Use of Proton Pump Inhibitors on the Risk of Community Acquired Infections. (UTOPIE)

Community Infections

France
AstraZeneca
i3 Innovus

Completed

Partial Response to Proton Pump Inhibitors (PPI) Treatment: The Cost to Society and the Burden to the Patient - a Study in the US (REMAIN)

Gastroesophageal Reflux Disease (GERD)

United States
Medical University of Graz

Completed

The Gastrointestinal Microbiome of Infants With GERD and PPI Therapy: a Pilot Study

Gastroesophageal Reflux

Austria
University of Arizona
Janssen Pharmaceutica N.V., Belgium; Southern Arizona VA Health Care System

Completed

Role of Pain Modulation in GERD Patients Who Failed Standard Dose Proton Pump Inhibitors (PPI)

Gastroesophageal Reflux Disease

United States
Centre Hospitalier Universitaire de Nice

Recruiting

PPI Supplementation to Fight ECtopIc Calcification in PXE (PROPHECI-PPI)

Pseudoxanthoma Elasticum

France
Novartis

Completed

Assessment of the Role of Tegaserod Therapy in the Management of Gastroesophageal Reflux Disease (GERD) Symptoms in Patients With Incomplete Response to Proton Pump Inhibitors (PPIs).

Gastroesophageal Reflux Disease (GERD)

United States
Novartis

Completed

The Role of Tegaserod Therapy in the Management of Dyspeptic Symptoms in Female Patients on Proton Pump Inhibitors for the Treatment of Heartburn.

Dyspepsia

United States
University Hospital, Angers

Completed

Physical Exercise Prescription With PEdometeR in General Practice for Patients With Cardiovascular Risk Factors - PEPPER (PEPPER)

Cardiovascular Diseases | Hypertension | Diabetes Mellitus, Type 2 | Sedentary Lifestyle | Hypercholesterolemia

France
Meridian Bioscience, Inc.
Rabin Medical Center

Completed

13-C Urea Breath Test Using BreathID System and PPIs (Proton Pump Inhibitors)

Helicobacter Pylori Infection

Israel
Chinese University of Hong Kong

Completed

ASP (PPI_H2RA) Study-H2RA Versus PPI for the Prevention of Recurrent UGIB in High-risk Users of Low-dose ASA

Upper Gastrointestinal Bleeding

Hong Kong, Japan
University of Copenhagen

Completed

Pan European Collaboration on Antipsychotic Naïve Schizophrenia II (PECANSII)

Schizophrenia

Denmark
Universitaire Ziekenhuizen KU Leuven

Recruiting

Primary carE PPi dEprescRibing Trial (PEPPER)

Dyspepsia | Heartburn | Reflux

Belgium
Centre Hospitalier Universitaire de Saint Etienne

Completed

Autonomic Nervous System Reactivity of the Newborn After a Nociceptive Stress: Interest of Sucrose and Non-nutritive Sucking (BBSUCROSE)

Newborn | Neonatal Screening

France
Minia University

Completed

Preoperative PPI in Sleeve Gastrectomy

Morbid Obesity

Egypt
VA Office of Research and Development
VHA Pharmacy Benefits Management Services VA Center For Medication Safety

Completed

Evaluation of the National Randomized Proton Pump Inhibitor De-prescribing (RaPPID) Program (RaPPID)

Proton Pump Inhibitors

United States
Ironwood Pharmaceuticals, Inc.

Terminated

A Trial of IW-3718 for 8 Weeks in Patients With Persistent Gastroesophageal Reflux Disease (GERD) Receiving Proton Pump Inhibitors (PPIs)

Gastroesophageal Reflux Disease (GERD)

Canada, United States
Yonsei University

Completed

Treatment Response of Maintenance Dose of Proton Pump Inhibitor in Patients With Nonerosive Gatroesophageal Reflux Disease

Non-erosive Gatroesophageal Reflux Disease

Korea, Republic of
Ironwood Pharmaceuticals, Inc.

Completed

Trial of IW-3718 for 8 Weeks in Patients With Persistent Gastroesophageal Reflux Disease (GERD) Receiving Proton Pump Inhibitors (PPIs)

Gastroesophageal Reflux Disease (GERD)

United States, Canada
Università degli Studi di Ferrara

Unknown

Effect of Proton Pump Inhibitor on Residual Platelet Reactivity After Clopidogrel in Homogenous Genetic Strata (GENIOUS)

Coronary Stenting

Italy
AstraZeneca

Completed

PPI Sequencing Study

Gastro-Oesophageal Reflux Disease

United Kingdom
HaEmek Medical Center, Israel
Technion, Israel Institute of Technology

Unknown

The Characteristics of Prepulse Inhibition in Children and Adolescents Suffering From Attention Deficit Disorder (PPI)

Attention Deficit Disorder

Israel

Search clinical trials for: Patient and Public Involvement (PPI)

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Egypt

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations